ConductScience.org, home

Trial · NCT01308749

Results by group22

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants Who Could Tolerate Twice Daily OxytocinSequence 2: Placebo:Oxytocin13Participants
Number of Participants Who Could Tolerate Twice Daily OxytocinSequence 1: Oxytocin:Oxytocin11Participants
Number of Participants Who Could Tolerate Twice Daily OxytocinSequence 2: Placebo:Oxytocin11Participants
Number of Participants Who Could Tolerate Twice Daily OxytocinSequence 2: Oxytocin:Oxytocin11Participants
Change in Mean Plasma Oxytocin Level During Period 1 - Double Blind PhaseSequence 2: Placebo:Oxytocin-0.69Standard Deviation 1.69picograms/mL (pg/mL)
Change in Mean Plasma Oxytocin Level During Period 1 - Double Blind PhaseSequence 1: Oxytocin:Oxytocin-0.15Standard Deviation 1.53picograms/mL (pg/mL)
Change in Mean WeightSequence 1: Oxytocin-oxytocin1.4Standard Error 1.3pounds
Change in Mean WeightSequence 2: Placebo :Oxytocin2.4Standard Error 0.7pounds
Change in Mean Total Social Social Responsiveness Scale (SRS) T-scoreSequence 1: Oxytocin-oxytocin-5.1Standard Error 2.3T-scores
Change in Mean Total Social Social Responsiveness Scale (SRS) T-scoreSequence 2: Placebo :Oxytocin-3.9Standard Error 3.3T-scores
Change in Mean Autism Diagnostic Observation Schedule (ADOS) Total ScoreSequence 1: Oxytocin-oxytocin-0.36Standard Error 0.39scores on a scale
Change in Mean Autism Diagnostic Observation Schedule (ADOS) Total ScoreSequence 2: Placebo :Oxytocin-0.31Standard Error 0.29scores on a scale
Change in Mean Aberrant Behavior Checklist (ABC)-Social Withdrawal Subscale Score Over Both PeriodsSequence 1: Oxytocin-oxytocin-3.7Standard Error 1.0scores on a scale
Change in Mean Aberrant Behavior Checklist (ABC)-Social Withdrawal Subscale Score Over Both PeriodsSequence 2: Placebo :Oxytocin-2.2Standard Error 1.9scores on a scale
Change in Mean Pervasive Developmental Disorder Behavior Inventory - Screening Version (PDDBI-SV) Total Score Over Both PeriodsSequence 1: Oxytocin-oxytocin-3.6Standard Error 2.4scores on a scale
Change in Mean Pervasive Developmental Disorder Behavior Inventory - Screening Version (PDDBI-SV) Total Score Over Both PeriodsSequence 2: Placebo :Oxytocin-3.0Standard Error 2.2scores on a scale
Change in Mean Systolic Blood Pressure During Period 1Sequence 1: Oxytocin-oxytocin-7.6Standard Error 2.8millimeters of mercury (mmHg)
Change in Mean Systolic Blood Pressure During Period 1Sequence 2: Placebo :Oxytocin1.5Standard Error 3.2millimeters of mercury (mmHg)
Mean Change in Prolactin Levels Over Period 1Sequence 1: Oxytocin-oxytocin-3.6Standard Error 2.68nanograms per milliliter (ng/mL)
Mean Change in Prolactin Levels Over Period 1Sequence 2: Placebo :Oxytocin1.17Standard Error 1.63nanograms per milliliter (ng/mL)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01308749/results